Naveris Inc.TM is a molecular diagnostics company developing and commercializing blood and saliva tests to transform the early detection and clinical management of viral-driven cancers. The company’s NavDx® test, which uses proprietary technology to detect tumor-tissue–modified HPV (TTMV®) DNA, is ordered by 150+ medical centers across the US.